Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Baxdrostat SCHEMBL14799508 | 1.00 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| Baxdrostat SCHEMBL30768266 | 1.00 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| Baxdrostat SCHEMBL14799507 | 1.00 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| Baxdrostat SCHEMBL14799753 | 1.00 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL31180372 | 0.96 | CYP11B2 (0.93) | CYP11B2CYP11B1 | |
| SCHEMBL14799875 | 0.95 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL14799650 | 0.95 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL14799849 | 0.95 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL31180329 | 0.94 | CYP11B2 (0.88) | CYP11B2CYP11B1 | |
| SCHEMBL31180342 | 0.93 | CYP11B2 (0.87) | CYP11B2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240277698-A1 | METHODS OF USING ALDOSTERONE SYNTHASE INHIBITORS | CINCOR PHARMA, INC. | 2024-08-22 | — | — | US | disclosed |
| CN-117545482-A | Methods of using aldosterone synthase inhibitors | 新科药业公司 | 2024-02-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240277698-A1 | METHODS OF USING ALDOSTERONE SYNTHASE INHIBITORS | HSD11B1, CYP17A1, CYP21A2 | CYP11B2 7/4885CYP11B1 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.